Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J. Aguirre, William C. Hahn, Robin M. Meyers et al.|Cancer Discovery|2016Cited by 632
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiationKimberly Stegmaier, Todd R. Golub|Nature Genetics|2004Cited by 269
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Kimberly Stegmaier|Journal of Clinical Investigation|2017Cited by 159
Gefitinib induces myeloid differentiation of acute myeloid leukemiaKimberly Stegmaier, Todd R. Golub|Blood|2005Cited by 127
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemiaVersha Banerji, Kimberly Stegmaier|Journal of Clinical Investigation|2012Cited by 104